IL25 and Crohn disease: Then, ileal biopsies obtained from SpA patients who developed clinically overt Crohn’s disease after treatment with IL-17i (n = 5) were analyzed for expression of IL-23/Th-17 related cytokines, IL-25/IL-17E-producing cells and type-2 innate lymphoid cells (ILC2s).